UK markets open in 1 hour 1 minute
  • NIKKEI 225

    27,818.83
    +535.24 (+1.96%)
     
  • HANG SENG

    26,240.01
    +278.98 (+1.07%)
     
  • CRUDE OIL

    73.18
    -0.77 (-1.04%)
     
  • GOLD FUTURES

    1,815.00
    -2.20 (-0.12%)
     
  • DOW

    34,935.47
    -149.03 (-0.42%)
     
  • BTC-GBP

    28,602.65
    -1,595.09 (-5.28%)
     
  • CMC Crypto 200

    963.85
    +13.95 (+1.47%)
     
  • ^IXIC

    14,672.68
    -105.62 (-0.71%)
     
  • ^FTAS

    4,030.24
    -23.88 (-0.59%)
     

Private equity firm poised to sweeten UDG bid after investor opposition

·1-min read

(Reuters) - Private equity firm Clayton, Dubilier & Rice (CD&R) was planning to increase its offer to buy UDG Healthcare to 2.72 billion pounds ($3.79 billion), the London-listed company said on Friday, following investor opposition to a previously agreed bid.

Ireland-based UDG said the potential 1,080 pence per share offer would be CD&R's final, adding that it plans to recommend the proposal. In May, both the companies had agreed to a 1,023 pence per share offer.

While UDG's board backed the first offer, its largest shareholder Allianz Global Investors said last month the bid was "opportunistic and significantly undervalues UDG and its prospects".

Activist investor Elliott took a stake in UDG weeks after the first offer was made, while media reports said investor M&G was also not in favour of CD&R's previous proposal.

UDG said on Friday it had not received any other buyout proposals.

($1 = 0.7182 pounds)

(Reporting by Pushkala Aripaka and Yadarisa Shabong in Bengaluru; Editing by Shounak Dasgupta)

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting